The Business Model of Retro Biosciences
As of August 26, 2026
Retro Biosciences is a privately held biotechnology company founded in 2021 and headquartered in Redwood City, California. The company develops therapies intended to address biological mechanisms of aging and meaningfully reverse age-related diseases.
Its research and development programs include autophagy enhancement, hematopoietic stem-cell reprogramming, microglia therapeutics, tissue reprogramming, AI-designed protein therapeutics, and chemical rejuvenation. Its pipeline includes RTR242, an oral therapeutic intended to boost autophagic flux that the company reports is in a Phase 1 clinical trial for Alzheimer's disease.
Hard Facts
Business Model Canvas
Unlock Premium Content
Get full access to 500+ Business Model Analyzes with Premium and discover the full scope!
Sign up for freeBusiness Model Patterns
Unlock Premium Content
Get full access to 500+ Business Model Analyzes with Premium and discover the full scope!
Sign up for free
SWOT Analysis
Unlock Premium Content
Get full access to 500+ Business Model Analyzes with Premium and discover the full scope!
Sign up for freeWhat makes Retro Biosciences special?
Unlock Premium Content
Get full access to 500+ Business Model Analyzes with Premium and discover the full scope!
Sign up for freeMarketing Insights
Unlock Premium Content
Get full access to 500+ Business Model Analyzes with Premium and discover the full scope!
Sign up for free